FDA calls on firms to be ‘recall ready’ in final guidance
Regulatory NewsJoanne S. Eglovitch
BiologicsComplianceMedical DevicesNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiologicsComplianceMedical DevicesNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy